XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events (Details) - Subsequent Event - Atrin Pharmaceuticals, Inc
May 16, 2022
shares
Subsequent events  
Common stock issued upon conversion (in shares) 10
Contingent value right period 2 years
Contingent value rights distribution period 30 days
Common Stock  
Subsequent events  
Equity issued upon business combination (in shares) 1,117,394
Series A convertible preferred stock  
Subsequent events  
Equity issued upon business combination (in shares) 2,949,630
Shareholders prior to acquisition  
Subsequent events  
Percentage of outstanding shares 41.20%
Atrin Pharmaceuticals, Inc  
Subsequent events  
Percentage of outstanding shares 58.80%